Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
13
GNS Quote, Financials, Valuation and Earnings
Last price:
$0.58
Seasonality move
:
328.65%
Day range:
$0.54 - $0.63
52-week range:
$0.51 - $7.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.10x
P/B ratio:
0.91x
Volume:
3.2M
Avg. volume:
11M
1-year change:
-92.66%
Market cap:
$12.7M
Revenue:
$23.1M
EPS (TTM):
--
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.9M | $7.6M | $8.3M | $18.2M | $23.1M | |
| Revenue Growth (YoY) | -- | -23.27% | 8.66% | 119.34% | 26.76% | |
| Cost of Revenues | $5M | $4.1M | $5.5M | $9.6M | $11.1M | |
| Gross Profit | $4.9M | $3.5M | $2.8M | $8.6M | $11.9M | |
| Gross Profit Margin | 49.5% | 45.85% | 33.24% | 47.49% | 51.76% | |
| R&D Expenses | $360.9K | $378K | $456.2K | $847.1K | $879.4K | |
| Selling, General & Admin | $6.6M | $5.5M | $6.8M | $18.4M | $25.8M | |
| Other Inc / (Exp) | $1.9M | $289.9K | -$166.2K | -$42.3M | $17.5M | |
| Operating Expenses | $7.1M | $6.1M | $6.8M | $22.1M | $32.6M | |
| Operating Income | -$2.1M | -$2.6M | -$4M | -$13.5M | -$20.6M | |
| Net Interest Expenses | $863.9K | $854K | $449.6K | $1.3M | $3.7M | |
| EBT. Incl. Unusual Items | -$1.1M | -$3.1M | -$4.6M | -$57.1M | -$6.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $111.3K | $69.3K | -$128.9K | -$1.1M | -$1.1M | |
| Net Income to Company | -$1.2M | -$3.2M | -$4.5M | -$56M | -$5.7M | |
| Minority Interest in Earnings | -- | $75.2K | $174K | $206K | $54.1K | |
| Net Income to Common Excl Extra Items | -$1.2M | -$3.1M | -$4.3M | -$55.8M | -$5.7M | |
| Basic EPS (Cont. Ops) | -$0.57 | -$1.45 | -$2.01 | -$24.70 | -$1.00 | |
| Diluted EPS (Cont. Ops) | -$0.57 | -$1.45 | -$2.01 | -$24.70 | -$1.00 | |
| Weighted Average Basic Share | $2.2M | $2.2M | $2.2M | $2.3M | $5.6M | |
| Weighted Average Diluted Share | $2.2M | $2.2M | $2.2M | $2.3M | $5.6M | |
| EBITDA | $1.1M | -$642.8K | -$2.6M | -$53.4M | $220.8K | |
| EBIT | -$150.7K | -$2.2M | -$4.2M | -$55.7M | -$3.1M | |
| Revenue (Reported) | $9.9M | $7.6M | $8.3M | $18.2M | $23.1M | |
| Operating Income (Reported) | -$2.1M | -$2.6M | -$4M | -$13.5M | -$20.6M | |
| Operating Income (Adjusted) | -$150.7K | -$2.2M | -$4.2M | -$55.7M | -$3.1M | |
| Period Ending | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -$676.6K | $3.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -$478.2K | $34.8K | |
| Gross Profit | -- | -- | -- | -$198.5K | $3.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $1.7M | $7.7M | |
| Other Inc / (Exp) | -- | -- | -- | -$309.5K | -$42M | |
| Operating Expenses | -- | -- | -- | $1.4M | $11.4M | |
| Operating Income | -- | -- | -- | -$1.6M | -$7.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$2.3M | -$50.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$91.1K | -$1M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$2M | -$49.7M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$0.93 | -$21.70 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.93 | -$21.70 | |
| Weighted Average Basic Share | -- | -- | -- | $2.2M | $3.1M | |
| Weighted Average Diluted Share | -- | -- | -- | $2.2M | $3.1M | |
| EBITDA | -- | -- | -- | -$1.9M | -$48.7M | |
| EBIT | -- | -- | -- | -$1.9M | -$49.7M | |
| Revenue (Reported) | -- | -- | -- | -$676.6K | $3.8M | |
| Operating Income (Reported) | -- | -- | -- | -$1.6M | -$7.7M | |
| Operating Income (Adjusted) | -- | -- | -- | -$1.9M | -$49.7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $7.6M | $12.8M | $12.7M | $23.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $4.1M | -- | -- | $11.1M | |
| Gross Profit | -- | $3.5M | -- | -- | $11.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $378K | -- | -- | -- | |
| Selling, General & Admin | -- | $5.5M | -- | -- | $25.8M | |
| Other Inc / (Exp) | -- | $289.9K | -- | -- | $17.5M | |
| Operating Expenses | -- | $6.1M | -- | -- | $32.6M | |
| Operating Income | -- | -$2.6M | -- | -- | -$20.6M | |
| Net Interest Expenses | -- | $854K | -- | -- | $3.7M | |
| EBT. Incl. Unusual Items | -- | -$3.1M | -- | -- | -$6.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $69.2K | -- | -- | -$1.1M | |
| Net Income to Company | -- | -$3.2M | -- | -- | -$5.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$3.1M | -- | -- | -$5.7M | |
| Basic EPS (Cont. Ops) | -- | -$1.45 | -- | -- | -$2.51 | |
| Diluted EPS (Cont. Ops) | -- | -$1.45 | -- | -- | -$2.51 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -$642.8K | -- | -- | $220.8K | |
| EBIT | -- | -$2.2M | -- | -- | -$3.1M | |
| Revenue (Reported) | -- | $7.6M | $12.8M | $12.7M | $23.1M | |
| Operating Income (Reported) | -- | -$2.6M | -- | -- | -$20.6M | |
| Operating Income (Adjusted) | -- | -$2.2M | -- | -- | -$3.1M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.3M | $2.3M | $1.8M | $5.7M | $614.8K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.3M | $948.3K | $1M | $4.9M | $1.9M | |
| Inventory | $119.5K | $112.5K | $92.5K | $1M | $755.3K | |
| Prepaid Expenses | $1.1M | $1.5M | $3.4M | $964K | $641.5K | |
| Other Current Assets | -- | -- | $80.5K | $126.8K | $25.2K | |
| Total Current Assets | $5.8M | $4.9M | $6.5M | $24.3M | $9.6M | |
| Property Plant And Equipment | $9.6M | $9.3M | $7.9M | $12.1M | -$627.9K | |
| Long-Term Investments | $28.5K | $29.1K | $29.1K | $29.1K | $29.1K | |
| Goodwill | $1.2M | $1.2M | $1.3M | $31.7M | $11.4M | |
| Other Intangibles | $922.4K | $1M | $1.4M | $17.2M | $16.3M | |
| Other Long-Term Assets | -- | -- | $501.8K | $26.1K | $18.9K | |
| Total Assets | $17.6M | $17M | $17.6M | $91.3M | $43.2M | |
| Accounts Payable | $486.9K | $821.8K | $1.1M | $1.7M | $4.4M | |
| Accrued Expenses | $1.3M | $1.3M | $1.6M | $2.5M | $723.6K | |
| Current Portion Of Long-Term Debt | $497.2K | $655.1K | $998.7K | $9.6M | $7.5M | |
| Current Portion Of Capital Lease Obligations | $544.6K | $545.1K | $436.3K | $1.6M | -- | |
| Other Current Liabilities | -- | $250K | $250K | -- | -- | |
| Total Current Liabilities | $6.2M | $5.4M | $7.1M | $23.4M | $17.2M | |
| Long-Term Debt | $3.5M | $1.7M | $852.1K | $2.7M | $254.5K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12.2M | $9.3M | $9.6M | $77.3M | $23.5M | |
| Common Stock | $26.8M | $50.6M | $50.9M | $108.6M | $81.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $5.3M | $7.4M | $3.6M | $7.2M | $14M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $257.2K | $4.3M | $6.8M | $5.7M | |
| Total Equity | $5.3M | $7.7M | $8M | $14M | $19.7M | |
| Total Liabilities and Equity | $17.6M | $17M | $17.6M | $91.3M | $43.2M | |
| Cash and Short Terms | $3.3M | $2.3M | $1.8M | $5.7M | $614.8K | |
| Total Debt | $4M | $2.3M | $1.9M | $12.2M | $7.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $2.3M | $1.8M | $5.7M | $614.8K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $948.3K | $1M | $4.9M | $1.9M | |
| Inventory | -- | $112.5K | $92.5K | $1M | $755.3K | |
| Prepaid Expenses | -- | $1.5M | $3.4M | $964K | $641.5K | |
| Other Current Assets | -- | -- | $80.5K | $126.8K | $25.2K | |
| Total Current Assets | -- | $4.9M | $6.5M | $24.3M | $9.6M | |
| Property Plant And Equipment | -- | $9.3M | $7.9M | $12.1M | -$627.9K | |
| Long-Term Investments | -- | $29.1K | $29.1K | $29.1K | $29.1K | |
| Goodwill | -- | $1.2M | $1.3M | $31.7M | $11.4M | |
| Other Intangibles | -- | $1M | $1.4M | $17.2M | $16.3M | |
| Other Long-Term Assets | -- | -- | $501.8K | $26.1K | $18.9K | |
| Total Assets | -- | $17M | $17.6M | $91.3M | $43.2M | |
| Accounts Payable | -- | $821.8K | $1.1M | $1.7M | $4.4M | |
| Accrued Expenses | -- | $1.3M | $1.6M | $2.5M | $723.6K | |
| Current Portion Of Long-Term Debt | -- | $655.1K | $998.7K | $9.6M | $7.5M | |
| Current Portion Of Capital Lease Obligations | -- | $545.1K | $436.3K | $1.6M | -- | |
| Other Current Liabilities | -- | $250K | $250K | -- | -- | |
| Total Current Liabilities | -- | $5.4M | $7.1M | $23.4M | $17.2M | |
| Long-Term Debt | -- | $1.7M | $852.1K | $2.7M | $254.5K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $9.3M | $9.6M | $77.3M | $23.5M | |
| Common Stock | -- | $50.6M | $50.9M | $108.6M | $81.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $257.2K | $4.3M | $6.8M | $5.7M | |
| Total Equity | -- | $7.7M | $8M | $14M | $19.7M | |
| Total Liabilities and Equity | -- | $17M | $17.6M | $91.3M | $43.2M | |
| Cash and Short Terms | -- | $2.3M | $1.8M | $5.7M | $614.8K | |
| Total Debt | -- | $2.3M | -- | -- | $7.8M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.2M | -$3.2M | -$4.5M | -$56M | -$5.7M | |
| Depreciation & Amoritzation | $1.3M | $1.6M | $1.6M | $2.4M | $3.3M | |
| Stock-Based Compensation | $171.8K | $398.6K | $293.8K | $1.3M | $532.5K | |
| Change in Accounts Receivable | -$557K | $153.7K | -$96.6K | $1.1M | $2.6M | |
| Change in Inventories | -$27.8K | $7K | $20K | -$545.5K | $121K | |
| Cash From Operations | -$1.3M | -$2.1M | -$2.9M | -$7.4M | -$12.4M | |
| Capital Expenditures | $1.1M | $671.6K | $882.1K | $1.2M | $569.3K | |
| Cash Acquisitions | -$785.2K | -$516.3K | -- | -$8.8M | -$2.3M | |
| Cash From Investing | -$1.8M | -$1.2M | -$956.2K | -$10.1M | -$2.8M | |
| Dividends Paid (Ex Special Dividend) | -$147.6K | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.3M | $1.8M | -- | $5.2M | $10.9M | |
| Long-Term Debt Repaid | -$218.6K | -$972.6K | -$830.5K | -$2.8M | -$1.4M | |
| Repurchase of Common Stock | -$656.5K | -- | -- | -- | -- | |
| Other Financing Activities | -$86.1K | $13.5K | $798.7K | -$471.8K | $1.5M | |
| Cash From Financing | $4M | $3.1M | $3M | $21.1M | $9.9M | |
| Beginning Cash (CF) | $2.7M | $3.3M | $2.3M | $1.8M | $5.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $848.8K | -$207.9K | -$855.1K | $3.6M | -$5.4M | |
| Ending Cash (CF) | $3.3M | $2.3M | $1.8M | $5.7M | $614.8K | |
| Levered Free Cash Flow | -$2.3M | -$2.8M | -$3.8M | -$8.7M | -$13M | |
| Period Ending | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$6.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $1.5M | |
| Stock-Based Compensation | -- | -- | -- | -- | $261.6K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$2.4M | |
| Change in Inventories | -- | -- | -- | -- | -$399.1K | |
| Cash From Operations | -- | -- | -- | -- | -$6.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -$8.8M | |
| Cash From Investing | -- | -- | -- | -- | -$9.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $4.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$1.3M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$128.9K | |
| Cash From Financing | -- | -- | -- | -- | $23.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $1.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | $76.1K | |
| Additions / Reductions | -- | -- | -- | -- | $7.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | $9M | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$3.2M | -- | -- | -$5.7M | |
| Depreciation & Amoritzation | -- | $1.6M | -- | -- | $3.3M | |
| Stock-Based Compensation | -- | $398.6K | -- | -- | $532.5K | |
| Change in Accounts Receivable | -- | $153.7K | -- | -- | $2.6M | |
| Change in Inventories | -- | $7K | -- | -- | $121K | |
| Cash From Operations | -- | -$2.1M | -$3.1M | -- | -$12.4M | |
| Capital Expenditures | -- | $671.6K | -- | -- | $569.3K | |
| Cash Acquisitions | -- | -- | -- | -- | -$2.3M | |
| Cash From Investing | -- | -$1.2M | -- | -- | -$2.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.8M | -- | -- | $10.9M | |
| Long-Term Debt Repaid | -- | -$972.6K | -- | -- | -$1.4M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $13.5K | -- | -- | $1.5M | |
| Cash From Financing | -- | $3.1M | -- | -- | $9.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$789.8K | -- | -- | -$4.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$2.8M | -- | -- | -$13M | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get GNS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GNS
Sector
P/E ratio
--
16.83x
PEG ratio
-0.01x
0.22x
P/B ratio
0.91x
1.45x
Price / LTM sales
0.10x
0.71x
Growth Metrics
GNS
Sector
Revenue growth
--
0.14%
Earnings growth
--
--
Revenue (5-year growth)
--
3.45%
Earnings forecast
--
$0.30
Profitability
GNS
Sector
Profitability FY 2023
$11.9M
$503.7M
Return on invested capital
--
5.17%
Return on assets
--
3.13%
Return on equity
--
7.63%
Earnings Date
Last Earnings Date
May
16
Next Earnings Date
Dec
24
Estimated Next Earnings Date
Aug
15
Balance Sheet
GNS
Sector
Total cash
--
$157.7M
Short term investments
--
$60.7M
Total assets
$43.2M
$1.7B
Long term debt
--
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
